LONDON – Candida albicans is a species of yeast that causes a number of infections in the human body. In addition to causing oral thrush and sore mouth, these micro-organisms can lead to serious illness or death. New research that provides a better understanding of how mucosal surfaces in the mouth respond to C. albicans to prevent tissue damage was presented recently.
The study was conducted by researchers at King’s College London. In laboratory tests, they exposed oral epithelial cells, a mucosal layer of cells that line the mouth, providing a barrier against microbes, to C. albicans in vitro and looked at particular gene expressions 6 and 24 hours after infection.
The phosphoinositide 3-kinase pathway, a molecular signalling pathway, was activated about 5 minutes after the specimen had come into contact with C. albicans, preventing the fungus from invading. The researchers suggested that the pathway is involved in priming epithelial cells to prevent future damage.
The researchers believe that the pathway may be an attractive target for new therapeutics. By boosting its activity, it may be possible to reduce tissue damage, suggested Dr David Moyes, research associate at the college.
According to the researchers, Candida infections are the third-most commonly acquired blood-borne infections, resulting in an estimated 50,000 deaths annually.
Moyes presented the findings at the Society for General Microbiology’s Autumn Conference, which finishes today at the University of Sussex.
LONDON, England: Treatment of head and neck cancer is notoriously complex, and only few advances have been made in the last 20 years. Last month, however, ...
NEWCASTLE, UK: Researchers and dentists from the UK are currently developing a new product from a marine microbe to protect dentures, teeth and gums from ...
LONDON, UK/CHENNAI, India: UK Research and Innovation and India’s Department of Biotechnology in the Ministry of Science and Technology have recently ...
What if we could replace the cumbersome process of validation for our devices, banking and other secure entry points with a flick of the tongue? According ...
LONDON, UK: Though the exact number of people who suffer from xerostomia is unclear, some studies estimate that as many as one in five of the population ...
HARLOW, UK: Now that many questions regarding COVID-19, including its symptoms, risks and recovery time, have been answered, researchers are faced with a ...
LONDON, UK: General awareness of mouth cancer in the UK remains dangerously low, despite more than 7,500 people being diagnosed with mouth cancer annually. ...
RUGBY, UK: In summer, people around the world poured a bucket of ice-cold water over their heads as part of a campaign initiated by the ALS (amyotrophic ...
CHENGDU, China: ChatGPT is an artificial intelligence (AI)-powered language model, capable of generating human-like text based on context and past ...
Live webinar
Thu. 11 September 2025
6:00 pm UTC (London)
Live webinar
Mon. 15 September 2025
6:00 pm UTC (London)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
4:00 pm UTC (London)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
5:30 pm UTC (London)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
6:00 pm UTC (London)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Wed. 17 September 2025
1:00 am UTC (London)
To post a reply please login or register